Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 1
1985 1
1986 1
1988 1
1991 2
1992 2
1994 3
1995 2
1996 1
1997 3
1998 3
1999 4
2000 7
2001 4
2002 1
2004 1
2006 2
2007 1
2008 3
2009 1
2010 2
2014 1
2015 3
2016 3
2017 2
2018 1
2020 6
2021 18
2022 12
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
[Surgery for Recurrent Lung Cancer].
Yotsukura M, Watanabe S. Yotsukura M, et al. Kyobu Geka. 2021 Sep;74(10):815-820. Kyobu Geka. 2021. PMID: 34548452 Japanese.
Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma.
Haga Y, Sakamoto Y, Kajiya K, Kawai H, Oka M, Motoi N, Shirasawa M, Yotsukura M, Watanabe SI, Arai M, Zenkoh J, Shiraishi K, Seki M, Kanai A, Shiraishi Y, Yatabe Y, Matsubara D, Suzuki Y, Noguchi M, Kohno T, Suzuki A. Haga Y, et al. Among authors: yotsukura m. Nat Commun. 2023 Dec 15;14(1):8375. doi: 10.1038/s41467-023-43732-y. Nat Commun. 2023. PMID: 38102134 Free PMC article.
Indocyanine green imaging for pulmonary segmentectomy.
Yotsukura M, Okubo Y, Yoshida Y, Nakagawa K, Watanabe SI. Yotsukura M, et al. JTCVS Tech. 2021 Jan 6;6:151-158. doi: 10.1016/j.xjtc.2020.12.005. eCollection 2021 Apr. JTCVS Tech. 2021. PMID: 34318180 Free PMC article.
Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy.
Shirasawa M, Yoshida T, Shiraishi K, Takigami A, Takayanagi D, Imabayashi T, Matsumoto Y, Masuda K, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Yotsukura M, Yoshida Y, Nakagawa K, Tsuchida T, Hamamoto R, Yamamoto N, Motoi N, Kohno T, Watanabe SI, Ohe Y. Shirasawa M, et al. Among authors: yotsukura m. Lung Cancer. 2023 May;179:107183. doi: 10.1016/j.lungcan.2023.107183. Epub 2023 Mar 25. Lung Cancer. 2023. PMID: 37037178
Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer.
Shirasawa M, Yoshida T, Shiraishi K, Goto N, Yagishita S, Imabayashi T, Matsumoto Y, Masuda K, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Yotsukura M, Yoshida Y, Nakagawa K, Naoki K, Tsuchida T, Hamamoto R, Yamamoto N, Motoi N, Kohno T, Watanabe SI, Ohe Y. Shirasawa M, et al. Among authors: yotsukura m. Br J Cancer. 2023 Dec;129(12):2003-2013. doi: 10.1038/s41416-023-02427-3. Epub 2023 Sep 20. Br J Cancer. 2023. PMID: 37731022
Rare but clinically important salivary gland-type tumor of the lung: A review.
Takamori S, Yatabe Y, Osoegawa A, Aokage K, Yoshioka H, Miyoshi T, Mimae T, Endo M, Hattori A, Yotsukura M, Isaka T, Isaka M, Maniwa T, Nakajima R, Watanabe SI. Takamori S, et al. Among authors: yotsukura m. Jpn J Clin Oncol. 2024 Feb 7;54(2):121-128. doi: 10.1093/jjco/hyad154. Jpn J Clin Oncol. 2024. PMID: 37952098 Review.
Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer.
Yotsukura M, Nakagawa K, Suzuki K, Takamochi K, Ito H, Okami J, Aokage K, Shiono S, Yoshioka H, Aoki T, Tsutani Y, Okada M, Watanabe SI; Lung Cancer Surgical Study Group (LCSSG) of the Japan Clinical Oncology Group (JCOG). Yotsukura M, et al. Jpn J Clin Oncol. 2021 Jan 1;51(1):28-36. doi: 10.1093/jjco/hyaa187. Jpn J Clin Oncol. 2021. PMID: 33147608 Review.
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revisions of the T-Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer.
Van Schil PE, Asamura H, Nishimura KK, Rami-Porta R, Kim YT, Bertoglio P, Cangir AK, Donington J, Fang W, Giroux DJ, Lievens Y, Liu H, Lyons G, Sakai S, Travis WD, Ugalde P, Jeffrey Yang CF, Yotsukura M, Detterbeck F; Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions. Van Schil PE, et al. Among authors: yotsukura m. J Thorac Oncol. 2024 May;19(5):749-765. doi: 10.1016/j.jtho.2023.12.006. Epub 2023 Dec 7. J Thorac Oncol. 2024. PMID: 38070600
101 results